XML 17 R46.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Compensation (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Number of Stock Options, Total outstanding at the beginning of the period 662,500  
Number of Stock Options, Options granted 490,000  
Number of Stock Options, Options forfeited (103,334)  
Number of Stock Options, Options exercised (16,666)  
Number of Stock Options, Total outstanding at the end of the period 1,032,500 662,500
Number of Stock Options, Total exercisable at December 31, 2019 687,917  
Weighted Average Exercise Price, Beginning of period $ 7.52  
Weighted Average Exercise Price, Granted 8.30  
Weighted Average Exercise Price, Forfeited 9.66  
Weighted Average Exercise Price, Exercised 9.61  
Weighted Average Exercise Price, End of period 7.73 $ 7.52
Weighted Average Exercise Price, Vested and Exercisable $ 7.37  
Weighted Average Remaining Contract Term, Total outstanding 3 years 3 months 29 days 3 years 4 months 2 days
Weighted Average Remaining Contract Term, Options granted 4 years 1 month 24 days  
Weighted Average Remaining Contract Term, Options forfeited 3 years 5 months 19 days  
Weighted Average Remaining Contract Term, Options exercised 2 years 11 months 27 days  
Weighted Average Remaining Contract Term Exercise Price, Vested and Exercisable 2 years 7 months 2 days  
Aggregate Intrinsic Value, Total outstanding Balance, Begining of the period $ 332,100  
Aggregate Intrinsic Value, Total outstanding Balance, End of the period 576,000 $ 332,100
Aggregate Intrinsic Value, Vested and Exercisable at December 31, 2019 $ 561,375